XWELL (XWEL) Stock Price, News & Analysis

Company Overview

XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Key Stats

• Today's Range: $1.41 to $1.47
• 50-Day Range: $1.04 to $1.58
• 52-Week Range: $0.26 to $2.20
• Volume: 54,771 shs
• Average Volume: 91,995 shs
• Market Capitalization: $12.15 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

XWELL Stock Analysis - MarketRank™

XWELL scored higher than 1% of companies evaluated by MarketBeat, and ranked 865th out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

XWELL has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

XWELL has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of XWELL is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of XWELL is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

XWELL has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.15% of the float of XWELL has been sold short.

Short Interest Ratio / Days to Cover

XWELL has a short interest ratio ("days to cover") of 4.85.

Change versus previous month

Short interest in XWELL has recently increased by 7.73%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

XWELL does not currently pay a dividend.

Dividend Growth

XWELL does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Sentiment

XWELL has a news sentiment score of -3.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for XWELL this week, compared to 1 article on an average week.

Search Interest

2 people have searched for XWEL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, XWELL insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.93% of the stock of XWELL is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

8.67% of the stock of XWELL is held by institutions.

Company Calendar

• Last Earnings: 5/20/2026
• Today: 5/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Personal Services
• Current Symbol: NASDAQ:XWEL
• CIK: 1410428
• Web: www.xwell.com
• Phone: (212) 750-9595
• Fax: 309-410-3967
• Employees: 360
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($5.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.99 million
• Net Margins: -81.43%
• Pretax Margin: -78.06%
• Return on Equity: -2,318.99%
• Return on Assets: -116.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.35
• Quick Ratio: 0.42

Sales & Book Value

• Annual Sales: $29.21 million
• Price / Sales: 0.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.19 per share
• Price / Book: 1.21

Miscellaneous

• Outstanding Shares: 8,440,000
• Free Float: 7,268,000
• Market Cap: $12.15 million
• Optionable: No Data
• Beta: 1.01